Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
Open | $2.74 |
Close | $2.80 |
Volume / Avg. | 1.09M / 1.24M |
Day Range | 2.66 - 2.84 |
52 Wk Range | 1.96 - 4.71 |
Market Cap | $371.20M |
P/E Ratio | 66.00 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 30.6% |
Days to Cover | 8.76 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Organogenesis Hldgs (NASDAQ:ORGO) through any online brokerage.
Other companies in Organogenesis Hldgs’s space includes: Cabaletta Bio (NASDAQ:CABA), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), Korro Bio (NASDAQ:KRRO) and Fate Therapeutics (NASDAQ:FATE).
There is no analysis for Organogenesis Hldgs.
Organogenesis Hldgs has a consensus price target of $10.75.
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $2.8 last updated June 28, 2024 at 4:04 PM EDT.
There are no upcoming dividends for Organogenesis Hldgs.
Organogenesis Hldgs’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Organogenesis Hldgs.
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.